Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study.
- 1 May 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 10 (3) , 379-385
- https://doi.org/10.1161/01.atv.10.3.379
Abstract
The apolipoprotein (apo) E structural locus has been shown to influence concentrations of total cholesterol, apo B, and low density lipoprotein (LDL) cholesterol in population studies. Apo E has six phenotypes resulting from three common alleles at this locus. In the present study, we have typed 473 healthy white women for apo E. At baseline in 1984, all women were premenopausal. To date, 109 of these women have become postmenopausal and are not on hormone therapy. Statistical analyses were done on both pre- and postmenopausal groups to assess the influence of menopausal status in combination with the apo E locus on lipid profile. Nine lipoprotein lipids and apolipoproteins were categorized by three apo E phenotypes: apo E3-2, apo E3-3, and apo E4-3. These were compared in analysis of variance. At baseline, the apo E3-2 phenotype showed the lowest average concentrations of total cholesterol (170 mg/dl), apo B (80 mg/dl), and LDL cholesterol (91 mg/dl), while the apo E4-3 phenotype demonstrated the highest average concentrations of total cholesterol (192 mg/dl), apo B (104 mg/dl), and LDL cholesterol (116 mg/dl) (p less than or equal to 0.0004). Apo E3-3 homozygotes were intermediate on all three quantitative variables. The postmenopausal subset showed the same trends by phenotype, with overall increases in total cholesterol, apo B, LDL cholesterol, and triglycerides, regardless of phenotype. Women who remained premenopausal generally showed smaller increases in these same measures. Our results suggest that, on average, the lower lipoprotein values for the apo E3-2 phenotype are maintained through early menopause despite a worsening of lipid profiles for all women as they age.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 33 references indexed in Scilit:
- Apolipoprotein E polymorphism in health and diseasePublished by Elsevier ,2004
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individualsAmerican Journal of Medical Genetics, 1987
- The Effect of Ovariectomy on Lipoprotein Metabolism during a Period of One Year1)Experimental and Clinical Endocrinology & Diabetes, 1986
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- Polymorphism at the Apoprotein‐E locus in relation to risk of coronary diseaseClinical Genetics, 1984
- Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.Journal of Clinical Investigation, 1983
- Apolipoprotein E polymorphism and coronary artery disease.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- Lipoprotein receptors and cholesterol homeostasisBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
- Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: Results from a prospective population study of women in Göteborg, SwedenPreventive Medicine, 1982